Effects of elexacaftor/tezacaftor/ivacaftor therapy on mental health of patients with cystic fibrosis

Introduction: The CFTR modulator drug elexacaftor/tezacaftor/ivacaftor (ETI) was shown to improve CFTR function and clinical symptoms in patients with cystic fibrosis (CF) with at least one F508del allele. Recently, some case reports suggested potential side effects of ETI on mental health with an i...

Descripción completa

Detalles Bibliográficos
Autores principales: Piehler, Linus, Thalemann, Ralf, Lehmann, Christine, Thee, Stephanie, Röhmel, Jobst, Syunyaeva, Zulfiya, Stahl, Mirjam, Mall, Marcus A., Graeber, Simon Y.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10160464/
https://www.ncbi.nlm.nih.gov/pubmed/37153809
http://dx.doi.org/10.3389/fphar.2023.1179208

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10160464/
https://www.ncbi.nlm.nih.gov/pubmed/37153809
http://dx.doi.org/10.3389/fphar.2023.1179208

Ejemplares similares